Lakey Jonathan R T, Mirbolooki Mohammadreza, Rogers Christina, Mohr Jim
Clinical Islet Transplant Program, Department of Surgery, Faculty of Medicine, University of Alberta, 8215 112 Street, Suite 210, College Plaza, T6G 2C8 Edmonton, AB, Canada.
Cell Tissue Bank. 2007;8(1):31-42. doi: 10.1007/s10561-006-9003-2.
There is relatively little known about the demand for allograft tissues in Canada. The Canadian Council for Donation and Transplantation (CCDT) is a national advisory body that undertook a comprehensive "market survey" to estimate surgical demand for human allograft tissues in Canada. The report "Demand for Human Allograft Tissue in Canada" reflects survey results sent to 5 prominent User Groups. User Groups were identified as orthopaedic surgeons; neurosurgeons; corneal transplant surgeons; plastic surgeons, specifically those at Canadian Burn Units; and cardiac surgeons (adult and paediatric surgery). The demand for allograft grafts was determined and then extrapolated across the total User Group and then increases in allograft tissue use over the next 1-2 years across User Groups were predicted. The overall response rate for the survey was 21.4%. It varied from a low of 19.6% for the orthopaedic survey to a high of 40.5% for the corneal survey. The estimated current demand for allograft tissue in Canada ranges from a low of 34,442 grafts per year to a high of 62,098 grafts per year. The predicted increase in use of allograft tissue over the next 1-2 year period would suggest that annual demand could rise to somewhere in the range of 42,589-72,210 grafts. The highest rated preferences (98% and 94%) were for accredited and Canadian tissue banks, respectively. This study represents a key step in addressing the paucity of information concerning the demand for allograft tissue in Canada.
关于加拿大同种异体移植组织的需求，人们了解得相对较少。加拿大捐赠与移植理事会（CCDT）是一个全国性咨询机构，它开展了一项全面的“市场调查”，以估算加拿大对人类同种异体移植组织的手术需求。《加拿大人类同种异体移植组织需求》报告反映了发送给5个主要用户群体的调查结果。用户群体被确定为骨科医生、神经外科医生、角膜移植外科医生、整形外科医生，特别是加拿大烧伤科的医生，以及心脏外科医生（成人和小儿外科）。确定了同种异体移植物的需求，然后推算至整个用户群体，并预测了未来1至2年各用户群体同种异体移植组织使用量的增长情况。该调查的总体回复率为21.4%。回复率从骨科调查的低至19.6%到角膜调查的高至40.5%不等。据估计，加拿大目前对同种异体移植组织的需求每年低至34442个移植物，高至62098个移植物。预计未来1至2年同种异体移植组织使用量的增长表明，年需求量可能增至42589至72210个移植物之间的某个数值。最高评级的偏好分别是认可的组织库（98%）和加拿大的组织库（94%）。这项研究是解决加拿大同种异体移植组织需求信息匮乏问题的关键一步。
